NCT05112172View on ClinicalTrials.gov

Effect of Oxygen Therapy for Patients With Precapillary Pulmonary Hypertension Who Experience an Altitude Related Adverse Health Effect (ARAHE) During 30h Exposure to 2500m

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

April 15, 2022

Study Completion Date

April 15, 2022

Conditions
High Altitude Pulmonary HypertensionOxygen Therapy
Interventions
OTHER

Oxygen Therapy

Oxygen Therapy in patients developing an altitude related adverse health effect (ARAHE) during 30h exposure to 2500m of high altitude

Trial Locations (1)

8091

Respiratory Clinic, University Hospital of Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT05112172 - Effect of Oxygen Therapy for Patients With Precapillary Pulmonary Hypertension Who Experience an Altitude Related Adverse Health Effect (ARAHE) During 30h Exposure to 2500m | Biotech Hunter | Biotech Hunter